Heath, Elisabeth I <br/><br/>
A phase I pharmacokinetic and safety evaluation of oral pazopanib dosing administered as crushed tablet or oral suspension in patients with advanced solid tumors.  [electronic resource] 

 -  Investigational new drugs  Aug 2012 
 - 1566-74 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-0646 
<br/><br/><label>Standard No.: </label>10.1007/s10637-011-9725-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--administration & dosage<br/>Demography<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Indazoles<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Neoplasms--drug therapy<br/>Pyrimidines--administration & dosage<br/>Sulfonamides--administration & dosage<br/>Suspensions<br/>Tablets<br/>Time Factors<br/>Treatment Outcome